BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Farmers Insurance
Express Scripts
Fish and Richardson

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,559,148

« Back to Dashboard

Summary for Patent: 5,559,148

Title: Parenteral busulfan for treatment of malignant disease
Abstract:Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy.
Inventor(s): Andersson; Borje S. (Houston, TX), Bhagwatwar; Harshal P. (Houston, TX), Chow; Diana S. (Houston, TX)
Assignee: Board of Regents, The University of Texas System (Austin, TX) University of Houston-University Park (Houston, TX)
Application Number:08/449,685
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition; Dosage form;

No matches for this query

International Patent Family for Patent: 5,559,148

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria197670► Subscribe
Australia694141► Subscribe
Australia7829094► Subscribe
Canada2171738► Subscribe
Germany69426334► Subscribe
Denmark0725637► Subscribe
European Patent Office0725637► Subscribe
Spain2153862► Subscribe
Greece3035447► Subscribe
Japan3599285► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: